S1 guideline diagnosis and therapy of cutaneous larva migrans (creeping disease)

J Dtsch Dermatol Ges. 2014 Jan;12(1):86-91. doi: 10.1111/ddg.12250.

Abstract

Guideline objectives: These guidelines aim to enhance patient care by optimizing the diagnosis and treatment of infections due to creeping disease (cutaneous larva migrans) and to raise awareness among doctors of current treatment options.

Methods: S1 guideline, non-systematic literature search, consensus process using a circular letter.

MeSH terms

  • Administration, Oral
  • Administration, Topical
  • Albendazole / administration & dosage*
  • Antinematodal Agents / administration & dosage*
  • Dermatology / standards*
  • Dose-Response Relationship, Drug
  • Germany
  • Humans
  • Ivermectin / administration & dosage*
  • Larva Migrans / diagnosis*
  • Larva Migrans / drug therapy*
  • Larva Migrans / parasitology
  • Larva Migrans / pathology
  • Practice Guidelines as Topic*

Substances

  • Antinematodal Agents
  • Ivermectin
  • Albendazole